Eli Lilly's Stock Plunges as Investors Eye Obesity-drug Competition

By Eleanor Laise 'Vast' weight-loss drug pipeline keeps Lilly in a strong position as field gets crowded, analysts say Eli Lilly & Co.'s stock was on pace for its worst day in about three years

MarketWatch13:21 ET

Express News | Shares of Weight Loss Stocks Are Trading Lower, Possibly on Continued Weakness Following Recent Weight Loss Data From Roche, Which Could Cause Competition Concerns for Companies in the Space

BenzingaJul 18 11:20 ET

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for

BenzingaJul 17 13:28 ET

Express News | Structure Therapeutics Shares Are Trading Lower Following Weight Loss Data From Competitor Roche

BenzingaJul 17 11:38 ET

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Viking Therapeutics Inc (NASDAQ:VKTX), and Structure Therapeutics Inc (NASDAQ:GPCR) stocks are trading lower on Wednesday.What happened?

BenzingaJul 17 10:47 ET

Roche Obesity-pill Trial Results Weigh on Shares of Eli Lilly, Novo Nordisk

By Eleanor Laise Selloff of weight-loss drug developers' stocks is overdone, some analysts say Shares of weight-loss drug developers including Eli Lilly & Co., Novo Nordisk and Structure

MarketWatchJul 17 09:03 ET